Comparative trial of low- and high-dose zonisamide as monotherapy for childhood epilepsy

So-Hee Eun, Heung Dong Kim, Baik-Lin Eun, In Kyu Lee, Hee Jung Chung, Joon Sik Kim, Hoon Chul Kang, Young Mock Lee, Eun Sook Suh, Dong Wook Kim, Soyong Eom, Joon Soo Lee, Han Ku Moon

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Purpose: To evaluate the effectiveness of zonisamide (ZNS) as monotherapy in children with newly diagnosed epilepsy. Methods: This randomized, multicenter trial included a 2-4-week titration and a 24-week maintenance phase after randomization to low-(3-4 mg/kg/day) or high-(6-8 mg/kg/day) dose groups as target maintenance dosages. The primary outcome measure was the seizure-free rate over 6 months, while a secondary measure was the change in cognition and behavior from screening to the end of the maintenance phase. Results: Out of 125 patients enrolled, 90 (49 low-dose and 41 high-dose) completed the study. Forty-one patients (63.1%) in the low-dose group and 34(57.6%) in the high-dose group achieved 6 months' freedom from seizures (p = 0.66). After treatment, the picture arrangement subtest improved in the low-dose group (p = 0.047) while the vocabulary subtest worsened in the high-dose group (p = 0.020). Comparing between the two groups, the vocabulary subtest in the high-dose group was significantly worse than that in the low-dose group (p = 0.002). Social competence, somatic complaints, depression/anxiety and delinquent and aggressive behavior in the low-dose group were significantly improved (p < 0.05). Moreover, total social competence, somatic complaints, delinquent behavior, externalizing, and total behavior problems were significantly more improved in the low-dose group than the high-dose group (p < 0.05). Conclusions: ZNS is an effective monotherapy for newly diagnosed childhood epilepsy. Lower doses of ZNS have a similar efficacy and more beneficial neurocognitive effects compared to higher doses. When prescribing higher doses of ZNS, one must be aware of the possible manifestation of problems associated with language development, such as those affecting vocabulary acquisition.

Original languageEnglish
Pages (from-to)558-563
Number of pages6
JournalSeizure
Volume20
Issue number7
DOIs
Publication statusPublished - 2011 Sep 1

Fingerprint

zonisamide
Vocabulary
Epilepsy
Maintenance
Seizures
Language Development
Random Allocation
Cognition
Multicenter Studies
Anxiety
Outcome Assessment (Health Care)
Depression

Keywords

  • Behavior
  • Child
  • Cognition
  • Epilepsy
  • Zonisamide

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Comparative trial of low- and high-dose zonisamide as monotherapy for childhood epilepsy. / Eun, So-Hee; Kim, Heung Dong; Eun, Baik-Lin; Lee, In Kyu; Chung, Hee Jung; Kim, Joon Sik; Kang, Hoon Chul; Lee, Young Mock; Suh, Eun Sook; Kim, Dong Wook; Eom, Soyong; Lee, Joon Soo; Moon, Han Ku.

In: Seizure, Vol. 20, No. 7, 01.09.2011, p. 558-563.

Research output: Contribution to journalArticle

Eun, S-H, Kim, HD, Eun, B-L, Lee, IK, Chung, HJ, Kim, JS, Kang, HC, Lee, YM, Suh, ES, Kim, DW, Eom, S, Lee, JS & Moon, HK 2011, 'Comparative trial of low- and high-dose zonisamide as monotherapy for childhood epilepsy', Seizure, vol. 20, no. 7, pp. 558-563. https://doi.org/10.1016/j.seizure.2011.04.005
Eun, So-Hee ; Kim, Heung Dong ; Eun, Baik-Lin ; Lee, In Kyu ; Chung, Hee Jung ; Kim, Joon Sik ; Kang, Hoon Chul ; Lee, Young Mock ; Suh, Eun Sook ; Kim, Dong Wook ; Eom, Soyong ; Lee, Joon Soo ; Moon, Han Ku. / Comparative trial of low- and high-dose zonisamide as monotherapy for childhood epilepsy. In: Seizure. 2011 ; Vol. 20, No. 7. pp. 558-563.
@article{9db692b090be4420a6ca663bd06e6874,
title = "Comparative trial of low- and high-dose zonisamide as monotherapy for childhood epilepsy",
abstract = "Purpose: To evaluate the effectiveness of zonisamide (ZNS) as monotherapy in children with newly diagnosed epilepsy. Methods: This randomized, multicenter trial included a 2-4-week titration and a 24-week maintenance phase after randomization to low-(3-4 mg/kg/day) or high-(6-8 mg/kg/day) dose groups as target maintenance dosages. The primary outcome measure was the seizure-free rate over 6 months, while a secondary measure was the change in cognition and behavior from screening to the end of the maintenance phase. Results: Out of 125 patients enrolled, 90 (49 low-dose and 41 high-dose) completed the study. Forty-one patients (63.1{\%}) in the low-dose group and 34(57.6{\%}) in the high-dose group achieved 6 months' freedom from seizures (p = 0.66). After treatment, the picture arrangement subtest improved in the low-dose group (p = 0.047) while the vocabulary subtest worsened in the high-dose group (p = 0.020). Comparing between the two groups, the vocabulary subtest in the high-dose group was significantly worse than that in the low-dose group (p = 0.002). Social competence, somatic complaints, depression/anxiety and delinquent and aggressive behavior in the low-dose group were significantly improved (p < 0.05). Moreover, total social competence, somatic complaints, delinquent behavior, externalizing, and total behavior problems were significantly more improved in the low-dose group than the high-dose group (p < 0.05). Conclusions: ZNS is an effective monotherapy for newly diagnosed childhood epilepsy. Lower doses of ZNS have a similar efficacy and more beneficial neurocognitive effects compared to higher doses. When prescribing higher doses of ZNS, one must be aware of the possible manifestation of problems associated with language development, such as those affecting vocabulary acquisition.",
keywords = "Behavior, Child, Cognition, Epilepsy, Zonisamide",
author = "So-Hee Eun and Kim, {Heung Dong} and Baik-Lin Eun and Lee, {In Kyu} and Chung, {Hee Jung} and Kim, {Joon Sik} and Kang, {Hoon Chul} and Lee, {Young Mock} and Suh, {Eun Sook} and Kim, {Dong Wook} and Soyong Eom and Lee, {Joon Soo} and Moon, {Han Ku}",
year = "2011",
month = "9",
day = "1",
doi = "10.1016/j.seizure.2011.04.005",
language = "English",
volume = "20",
pages = "558--563",
journal = "Seizure : the journal of the British Epilepsy Association",
issn = "1059-1311",
publisher = "W.B. Saunders Ltd",
number = "7",

}

TY - JOUR

T1 - Comparative trial of low- and high-dose zonisamide as monotherapy for childhood epilepsy

AU - Eun, So-Hee

AU - Kim, Heung Dong

AU - Eun, Baik-Lin

AU - Lee, In Kyu

AU - Chung, Hee Jung

AU - Kim, Joon Sik

AU - Kang, Hoon Chul

AU - Lee, Young Mock

AU - Suh, Eun Sook

AU - Kim, Dong Wook

AU - Eom, Soyong

AU - Lee, Joon Soo

AU - Moon, Han Ku

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Purpose: To evaluate the effectiveness of zonisamide (ZNS) as monotherapy in children with newly diagnosed epilepsy. Methods: This randomized, multicenter trial included a 2-4-week titration and a 24-week maintenance phase after randomization to low-(3-4 mg/kg/day) or high-(6-8 mg/kg/day) dose groups as target maintenance dosages. The primary outcome measure was the seizure-free rate over 6 months, while a secondary measure was the change in cognition and behavior from screening to the end of the maintenance phase. Results: Out of 125 patients enrolled, 90 (49 low-dose and 41 high-dose) completed the study. Forty-one patients (63.1%) in the low-dose group and 34(57.6%) in the high-dose group achieved 6 months' freedom from seizures (p = 0.66). After treatment, the picture arrangement subtest improved in the low-dose group (p = 0.047) while the vocabulary subtest worsened in the high-dose group (p = 0.020). Comparing between the two groups, the vocabulary subtest in the high-dose group was significantly worse than that in the low-dose group (p = 0.002). Social competence, somatic complaints, depression/anxiety and delinquent and aggressive behavior in the low-dose group were significantly improved (p < 0.05). Moreover, total social competence, somatic complaints, delinquent behavior, externalizing, and total behavior problems were significantly more improved in the low-dose group than the high-dose group (p < 0.05). Conclusions: ZNS is an effective monotherapy for newly diagnosed childhood epilepsy. Lower doses of ZNS have a similar efficacy and more beneficial neurocognitive effects compared to higher doses. When prescribing higher doses of ZNS, one must be aware of the possible manifestation of problems associated with language development, such as those affecting vocabulary acquisition.

AB - Purpose: To evaluate the effectiveness of zonisamide (ZNS) as monotherapy in children with newly diagnosed epilepsy. Methods: This randomized, multicenter trial included a 2-4-week titration and a 24-week maintenance phase after randomization to low-(3-4 mg/kg/day) or high-(6-8 mg/kg/day) dose groups as target maintenance dosages. The primary outcome measure was the seizure-free rate over 6 months, while a secondary measure was the change in cognition and behavior from screening to the end of the maintenance phase. Results: Out of 125 patients enrolled, 90 (49 low-dose and 41 high-dose) completed the study. Forty-one patients (63.1%) in the low-dose group and 34(57.6%) in the high-dose group achieved 6 months' freedom from seizures (p = 0.66). After treatment, the picture arrangement subtest improved in the low-dose group (p = 0.047) while the vocabulary subtest worsened in the high-dose group (p = 0.020). Comparing between the two groups, the vocabulary subtest in the high-dose group was significantly worse than that in the low-dose group (p = 0.002). Social competence, somatic complaints, depression/anxiety and delinquent and aggressive behavior in the low-dose group were significantly improved (p < 0.05). Moreover, total social competence, somatic complaints, delinquent behavior, externalizing, and total behavior problems were significantly more improved in the low-dose group than the high-dose group (p < 0.05). Conclusions: ZNS is an effective monotherapy for newly diagnosed childhood epilepsy. Lower doses of ZNS have a similar efficacy and more beneficial neurocognitive effects compared to higher doses. When prescribing higher doses of ZNS, one must be aware of the possible manifestation of problems associated with language development, such as those affecting vocabulary acquisition.

KW - Behavior

KW - Child

KW - Cognition

KW - Epilepsy

KW - Zonisamide

UR - http://www.scopus.com/inward/record.url?scp=79960926275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960926275&partnerID=8YFLogxK

U2 - 10.1016/j.seizure.2011.04.005

DO - 10.1016/j.seizure.2011.04.005

M3 - Article

VL - 20

SP - 558

EP - 563

JO - Seizure : the journal of the British Epilepsy Association

JF - Seizure : the journal of the British Epilepsy Association

SN - 1059-1311

IS - 7

ER -